Latest Listings And Ipos News

Karoon Energy has advanced a revised, phased development plan for its Neon offshore Brazil project into Front-End Engineering Design, with Phase 1 capital costs reduced to US$800-950 million. The project targets first oil in 2030, but a farm-down partner and further technical work remain prerequisites for a final investment decision.

Propel Funeral Partners says its acquisition engine remains funded after resilient first-quarter trading offset a temporary contraction in industry death volumes. Revenue and Operating EBITDA were each broadly flat year on year, while constant-currency growth was approximately 3%.

Litchfield Minerals has made a potential Harts Range partnership the centrepiece of its 2027 strategy, with BHP expected to take the project to its investment committee later this month. The explorer is also trimming holding costs, separating non-core assets and seeking a second drill-ready copper or gold project.

Elsight has secured its largest order yet from an unnamed U.S. defence OEM, taking the customer’s 2026 purchases to US$2 million. Deliveries are scheduled through the first quarter of 2027, extending revenue visibility while the company presses its U.S. growth strategy.

Metals X has secured an extension to decide whether to make a firm offer for First Tin, after submitting a revised non-binding cash proposal. The new deadline is 5.00pm London time on 20 November 2026, but the takeover remains uncertain.

Finbar has fully repaid the development facility backing its Garden Towers project after settlements began, leaving completed stock debt-free. The East Perth project has recorded $170.5 million in settled sales, with further proceeds expected to support H1 FY27 performance and return capital to the joint venture partners.

Starpharma is targeting a December start for first-in-human testing of its lead DEP HER2-Lu radiopharmaceutical, subject to ethics approval, as it shifts decisively toward targeted oncology. The company also outlined stronger funding, majority ownership of Petalion’s FAP program and a proposed Chair transition at its 2026 AGM.

Clinuvel has outlined a multi-year expansion from peptide therapeutics into polymers, long-acting injectables, devices and digital health, backed by A$220 million of planned FY2027-FY2030 spending. The strategy comes with a near-term setback: first patient treatment in the CUV107 vitiligo study has been delayed to February 2027.

Jumbo Interactive delivered record FY26 earnings despite a weak Australian jackpot cycle and reaffirmed its FY27 targets. The company is also pursuing a conditional A$6.45 million acquisition in Ontario while preparing for a CFO transition.

Marlin Global’s portfolio fell 6.3% in FY2026 while its benchmark gained 30.5%, prompting a tighter risk framework and a broader portfolio. The NZX-listed investment company has started FY2027 more strongly, but the recovery remains early.

Dotz Nano has secured a five-year ChillerAI services agreement covering six Israeli hotels, with indicative fees of about A$14,500 a month if the full portfolio is deployed. The performance-based contract starts at VERT Jerusalem, leaving revenue dependent on verified savings, approvals and rollout across the remaining sites.

Airbnb delivered a stronger third quarter, with revenue, bookings and profitability all accelerating, while lifting its full-year 2026 outlook and authorising a further US$12 billion share repurchase program. The company is also positioning AI, hotels and travel services as the next leg of growth.